secwatch.observer — SEC 8-K summary
======================================

Issuer:     EyePoint, Inc. (EYPT)
CIK:        0001314102
Form:       8-K
Filed at:   2023-03-02T23:59:59+00:00
Accession:  0000950170-23-005701
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

EyePoint FY2022 net product revenue $39.9M (+13% YoY); net loss $102.3M; cash $144.6M
--------------------------------------------------------------------------------

- FY2022 net product revenue $39.9M, up 13% from $35.3M; YUTIQ revenue $28.3M (+67% vs 2021).
- Net loss $102.3M ($2.74/share) vs $58.4M ($2.03/share) in FY2021; includes $20.7M DEXYCU impairment.
- Cash and investments $144.6M at Dec 31, 2022; cash runway projected into 2H 2024.
- Phase 2 DAVIO 2 (wet AMD) topline data expected by year-end 2023; Phase 2 PAVIA (NPDR) enrollment completion in Q4 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314102/000095017023005701/0000950170-23-005701-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314102/000095017023005701/eypt-20230302.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-005701

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer